Works matching IS 1082801X AND DT 2009 AND VI 44 AND IP 10
Results: 14
Specialty pharmacy's role in REMS, FDA's new drug safety program.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Drug watch. Atherosclerosis and hypertension.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
New molecular entity. Vibativ.
- Published in:
- 2009
- Publication type:
- Journal Article
FDA actions in brief.
- Published in:
- 2009
- Publication type:
- Journal Article
Fampridine-SR: a potassium-channel blocker for the improvement of walking ability in patients with MS.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Atherosclerosis and hypertension.
- Published in:
- Formulary, 2009, v. 44, n. 10, p. 312
- Publication type:
- Article
FDA leadership promotes scientific integrity, quality standards.
- Published in:
- Formulary, 2009, v. 44, n. 10, p. 310
- By:
- Publication type:
- Article
Specialty pharmacy's role in REMS, FDA's new drug safety program.
- Published in:
- Formulary, 2009, v. 44, n. 10, p. 300
- By:
- Publication type:
- Article
Fampridine-SR: A potassium-channel blocker for the improvement of walking ability in patients with MS.
- Published in:
- Formulary, 2009, v. 44, n. 10, p. 293
- By:
- Publication type:
- Article
New combination.
- Published in:
- Formulary, 2009, v. 44, n. 10, p. 292
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2009, v. 44, n. 10, p. 291
- Publication type:
- Article
New formulation.
- Published in:
- Formulary, 2009, v. 44, n. 10, p. 290
- Publication type:
- Article
New molecular entity.
- Published in:
- Formulary, 2009, v. 44, n. 10, p. 290
- Publication type:
- Article
Pipeline preview.
- Published in:
- Formulary, 2009, v. 44, n. 10, p. 290
- Publication type:
- Article